{
    "cancelStatus": "1",
    "cancelDate": "2017-04-20",
    "cancelReason": [
        "838"
    ],
    "licid": "02025254",
    "validDate": "2015-08-23 00:00:00.000",
    "issueDate": "2010-08-23 00:00:00.000",
    "licKind": "10",
    "oldLicid": null,
    "certNo": "DHA00202525409",
    "prodNameC": "特康黴素",
    "prodNameE": "Teicoplanin",
    "indicationsName": [
        "抗生素"
    ],
    "does": "0040",
    "packageUnit": [
        {
            "packageSpec": null,
            "packageUnit": "44"
        }
    ],
    "medMCode": "01",
    "maMedCode": null,
    "medDCode": null,
    "ingredientsDesc": [
        "teicoplanin, contains not less than 80% of teicoplanin A2 group (A2-1,A2-2,A2-3,A2-4,A2-5), contains not less than 15% of teicoplanin A3-1, and contains not less than 900ug(potency)per mg, calculated on the anhydrous, de-sodium chloride and de-residual solvents basis. The potency of Teicoplanin is expresses as mass(potency) of teicoplanin (C72-89H68-99C12N8-9O28-33)."
    ],
    "restraintItemsCode": [
        "02",
        "1Q"
    ],
    "applicantName": "百歐敏國際有限公司",
    "applicantAddr": "台北市中山區中山北路三段３０號１１樓之１",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "AXELLIA PHARMACEUTICALS AS",
            "factoryAddr": "HARBITZALLEEN 3, 0275 OSLO, NORWAY",
            "factoryCompanyAddr": null,
            "countryCode": "NO",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FNO0010000",
            "factoryInfo": null,
            "qsd": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsDesc": "teicoplanin, contains not less than 80% of teicoplanin A2 group (A2-1,A2-2,A2-3,A2-4,A2-5), contains not less than 15% of teicoplanin A3-1, and contains not less than 900ug(potency)per mg, calculated on the anhydrous, de-sodium chloride and de-residual solvents basis. The potency of Teicoplanin is expresses as mass(potency) of teicoplanin (C72-89H68-99C12N8-9O28-33).",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "J01XA02"
        }
    ]
}